Patent Yard Sign in
Canadian application, no grantCanada

Derivatives of cyclosporine a, antibodies directed thereto and uses thereof

CA 2004626 A1 · Owner: Cacalano, Nicholas A. · Inventors: Cleveland, William L.; Cacalano, Nicholas A.; Erlanger, Bernard F.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Abstract of the Disclosure This invention provides a molecule comprising cyclosporine A or a congener of cyclosporine A which is photochemically attached to a ligand containing a reactive group. This invention also provides a composition of matter which comprises a conjugate of a compound and the aforementioned molecule wherein the compound is bound to the molecule through the reactive group. This invention further provides an antibody directed to the aforementioned composition of matter specific for cyclosporine A or congener of cyclosporine A. Finally, this invention provides a method of monitoring levels of cyclosporine A or congener of cyclosporine A in a subject.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 5, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 5, 2009.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 5, 2011.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 5, 1989
GrantedNo grant recorded
Term endedDecember 5, 2009
Patent numberCA 2004626 A1
Classification (IPC)C12P21/08 +2 more

Timeline

Timeline From CIPO dates

1990199219941996199820002002200420062008Application filedDec 5, 1989Term endedDec 5, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.